Source link : https://yourblogdomain.com/2025/06/30/fda-approves-first-treatment-for-mas-in-still-disease/

Source link : https://newshealth.biz/health-news/fda-approves-first-treatment-for-mas-in-still-disease/ The FDA has approved the interferon gamma-blocking antibody emapalumab-lzsg (Gamifant) for the treatment of macrophage activation syndrome (MAS) in known or suspected Still disease. This is the first FDA-approved treatment for MAS in the United States. The indication is specifically for adult and pediatric (newborn and older) patients with MAS in […]

—-

Author : yourblogdomain

Publish date : 2025-06-30 19:41:00

Copyright for syndicated content belongs to the linked Source.

—-

12345678